TR199902995T2 - 9-Oksim eritromisin türevleri - Google Patents

9-Oksim eritromisin türevleri

Info

Publication number
TR199902995T2
TR199902995T2 TR1999/02995T TR9902995T TR199902995T2 TR 199902995 T2 TR199902995 T2 TR 199902995T2 TR 1999/02995 T TR1999/02995 T TR 1999/02995T TR 9902995 T TR9902995 T TR 9902995T TR 199902995 T2 TR199902995 T2 TR 199902995T2
Authority
TR
Turkey
Prior art keywords
compounds
formula
erythromycin derivatives
oxime erythromycin
methods
Prior art date
Application number
TR1999/02995T
Other languages
English (en)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR199902995T2 publication Critical patent/TR199902995T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Bulus, formül (I)'in bilesimleri ve onlarin farmasötik olarak uygun tuzlari ile ilgilidir, burada R1,R2,R6 ve X burada tanimlandigi gibidir. Bulus ayrica formül (I)'in bilesimlerini içeren farmasötik kompozisyonlar, bakteriyel ve protozoa enfeksiyonlarinin tedavisinde formül (I)'in sözü edilen bilesimlerini kullanma metodlari ve formül (i)'in sözü edilen bilesimlerinin hazirlanmasi için metodlar.
TR1999/02995T 1997-06-11 1998-05-15 9-Oksim eritromisin türevleri TR199902995T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
TR199902995T2 true TR199902995T2 (tr) 2000-02-21

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02995T TR199902995T2 (tr) 1997-06-11 1998-05-15 9-Oksim eritromisin türevleri

Country Status (31)

Country Link
EP (1) EP0988308A1 (tr)
JP (1) JP2000513026A (tr)
KR (1) KR20010013660A (tr)
CN (1) CN1259135A (tr)
AP (1) AP9801253A0 (tr)
AR (1) AR012244A1 (tr)
AU (1) AU7226798A (tr)
BG (1) BG103947A (tr)
BR (1) BR9810021A (tr)
CA (1) CA2293335A1 (tr)
CO (1) CO4940506A1 (tr)
CZ (1) CZ9904388A3 (tr)
EA (1) EA199901016A1 (tr)
GT (1) GT199800074A (tr)
HN (1) HN1998000073A (tr)
HR (1) HRP980316A2 (tr)
HU (1) HUP0002252A3 (tr)
ID (1) ID24529A (tr)
IL (1) IL132767A0 (tr)
IS (1) IS5251A (tr)
MA (1) MA26505A1 (tr)
NO (1) NO996108L (tr)
OA (1) OA11225A (tr)
PA (1) PA8451801A1 (tr)
PE (1) PE79899A1 (tr)
PL (1) PL337606A1 (tr)
TN (1) TNSN98083A1 (tr)
TR (1) TR199902995T2 (tr)
TW (1) TW448174B (tr)
WO (1) WO1998056800A1 (tr)
ZA (1) ZA985018B (tr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
WO2000017218A1 (en) * 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
KR20020007374A (ko) * 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
JP2003501439A (ja) * 1999-06-07 2003-01-14 アボット・ラボラトリーズ ６−ｏ−カルバメートケトライド誘導体
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048601A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
SI2550286T1 (sl) 2010-03-22 2016-04-29 Cempra Pharmaceuticals, Inc. Kristalne oblike makrolida in njihove uporabe
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
HUP0002252A2 (hu) 2000-12-28
IS5251A (is) 1999-11-16
BG103947A (en) 2000-07-31
IL132767A0 (en) 2001-03-19
AR012244A1 (es) 2000-09-27
GT199800074A (es) 1999-11-27
CO4940506A1 (es) 2000-07-24
ZA985018B (en) 1999-12-10
TW448174B (en) 2001-08-01
MA26505A1 (fr) 2004-12-20
EP0988308A1 (en) 2000-03-29
CA2293335A1 (en) 1998-12-17
EA199901016A1 (ru) 2000-06-26
PL337606A1 (en) 2000-08-28
HN1998000073A (es) 1999-01-08
ID24529A (id) 2000-07-20
HRP980316A2 (en) 1999-04-30
KR20010013660A (ko) 2001-02-26
AU7226798A (en) 1998-12-30
HUP0002252A3 (en) 2002-01-28
JP2000513026A (ja) 2000-10-03
TNSN98083A1 (fr) 2005-03-15
OA11225A (en) 2003-07-17
PE79899A1 (es) 1999-08-25
CZ9904388A3 (cs) 2002-10-16
BR9810021A (pt) 2000-09-19
CN1259135A (zh) 2000-07-05
NO996108D0 (no) 1999-12-10
AP9801253A0 (en) 1999-12-04
PA8451801A1 (es) 2000-05-24
NO996108L (no) 2000-02-10
WO1998056800A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
TR199902995T2 (tr) 9-Oksim eritromisin türevleri
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
TR200103395T2 (tr) 13-metil eritromisin türevleri.
CA2316919A1 (en) Novel macrolides
SE9504661D0 (sv) New compounds
DK41193D0 (da) Ionkanalaabnere
DE69720551D1 (de) Makrozyklische derivate von erythromycin a und b mit 13 ringatomen
EA199901014A1 (ru) C-4"-замещенные макролидные производные
ES2115760T3 (es) Derivados de 4''-desoxieritromicina.
CA2286511A1 (en) Novel macrolide derivatives
TR200200436T2 (tr) Yeni makrolit antibiyotikler
ATE259823T1 (de) Tricyclische erythromycinderivate
AP9801377A0 (en) Tricyclic erythromycin derivatives.
BR1100143A (pt) Composto, e, composição farmacêutica.
DE69330601D1 (de) Serotoninergische ergolin derivate
SE9504662D0 (sv) New compounds
AP9801235A0 (en) Erythromycin derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
TR199800340T1 (tr) Ön-ilaç 6-N-(L-ALA-L-ALA)-trovafloksasin polimorflari.
DK0874863T3 (da) 3-deoxy-3-descladinose-derivater fra erythromycin A og B
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
ECSP982529A (es) Derivados de la 9-oxima eritromicina